NKF 2010 Spring Meetings - Renal and Urology News

RSS | Login | Register

Follow our archived coverage from the 2010 National Kidney Foundation Spring Clinical Meetings in Orlando, Fla., including our four blogs below that were updated daily with three stories each.

Sections: Anemia | Hyperphosphatemia
Secondary Hyperparathyroidism | General News
More: Videos

Anemia Coverage - NKF Live 2010

Repeat Injections of Ferumoxytol Well Tolerated

Jody A. Charnow April 17, 2010

Ferumoxytol, a novel IV iron replacement therapy for CKD patients with iron deficiency anemia, is well tolerated regardless of the number of injections or interval between injections, show data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Iron Deficiency Common in CKD Patients

Jody A. Charnow April 17, 2010

Researchers who studied a group of non-dialysis CKD patients found that about one quarter of them suffered from iron deficiency anemia. They presented their findings at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Study Explores Novel Markers of CKD Anemia

Jody A. Charnow April 17, 2010

Mitochondrial DNA copy number (mtDNA) and plasma levels of hepcidin hold promise as novel markers of anemia in CKD patients, suggest data introduced at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Study Finds No Link Between FGF-23 and Dietary Phosphorus

Jody A. Charnow April 29, 2011

LAS VEGAS—Fibroblast growth factor 23 (FGF-23) is not significantly associated with dietary phosphorus or urinary phosphorus excretion, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Phosphate Binder May Reduce the Number of Hospitalization Days

Jody A. Charnow April 17, 2010

Using sevelamer instead of calcium-based binders (CBBs) to treat hyperphosphatemia in dialysis patients can significantly decrease the number of days of hospitalization, shows a new analysis presented at the National Kidney Foundation's 2010 Spring Clinical Meetings. .

Sevelamer Carbonate May Impair Calcitriol Bioavailability

Jody A. Charnow April 17, 2010

Sevelamer carbonate significantly decreases the bioavailability of oral calcitriol when the two drugs are administered together, but lanthanum carbonate does not, show data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Mineral Metabolism Unaffected by Ergocalciferol

John Schieszer June 18, 2010

Weekly (50,000 units) and monthly doses (50,000 units) of ergocalciferol treatment does not significantly impact markers of mineral metabolism (MM) in chronic hemodialysis (HD) patients, a study suggests.

Thrice-Weekly Post-Dialysis Cinacalcet A Viable Option

John Schieszer June 18, 2010

New approach may ease problems with noncompliance, according to researchers.

SHPT Treatment May Have CAC Benefit

John Schieszer June 10, 2010

Cinacalcet plus low-dose vitamin D for secondary hyperparathyroidism yielded encouraging results

Vascular Access After Graft Failure

Jody A. Charnow June 10, 2010

Central venous catheters (CVCs) are the most prevalent vascular access type in patients who initiate hemodialysis (HD) following a failed renal transplant, a study found.

Death Risk Is Lower With Peritoneal Dialysis

Jody A. Charnow April 19, 2010

Compared with incident hemodialysis (HD) patients, incident peritoneal dialysis (PD) patients, especially non-diabetics, show a robust and consistent survival advantage for up to five years, researchers reported at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Better Preparation Before Dialysis Improves Survival

Jody A. Charnow April 17, 2010

Patients with renal disease who are well prepared to start dialysis are significantly more likely to survive their first year of treatment, according to a study presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.